Fox Run Management L.L.C. Trims Holdings in Maximus, Inc. (NYSE:MMS)

Fox Run Management L.L.C. decreased its position in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 51.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,558 shares of the health services provider's stock after selling 9,220 shares during the quarter. Fox Run Management L.L.C.'s holdings in Maximus were worth $639,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. KLP Kapitalforvaltning AS bought a new stake in Maximus during the 4th quarter valued at $1,821,000. AXQ Capital LP acquired a new stake in shares of Maximus in the 4th quarter worth about $206,000. Hillsdale Investment Management Inc. lifted its position in Maximus by 0.4% in the 4th quarter. Hillsdale Investment Management Inc. now owns 52,400 shares of the health services provider's stock valued at $3,912,000 after acquiring an additional 230 shares in the last quarter. American Century Companies Inc. lifted its position in Maximus by 63.0% in the 4th quarter. American Century Companies Inc. now owns 21,547 shares of the health services provider's stock valued at $1,608,000 after acquiring an additional 8,332 shares in the last quarter. Finally, Quantbot Technologies LP boosted its stake in Maximus by 228.6% during the 4th quarter. Quantbot Technologies LP now owns 41,500 shares of the health services provider's stock valued at $3,098,000 after purchasing an additional 28,872 shares during the last quarter. Institutional investors own 97.21% of the company's stock.

Analysts Set New Price Targets

Several brokerages have recently commented on MMS. Raymond James raised Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price objective for the company in a research note on Thursday, January 2nd. StockNews.com lowered Maximus from a "buy" rating to a "hold" rating in a research report on Friday, February 14th.

Remove Ads

Insider Activity at Maximus

In other Maximus news, Director Jan Madsen sold 2,439 shares of the stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total transaction of $165,144.69. Following the completion of the transaction, the director now directly owns 18,097 shares of the company's stock, valued at approximately $1,225,347.87. This represents a 11.88 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Ilene R. Baylinson sold 14,500 shares of the firm's stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total value of $988,030.00. Following the completion of the sale, the insider now directly owns 2,512 shares of the company's stock, valued at $171,167.68. This represents a 85.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is owned by company insiders.

Maximus Stock Up 0.1 %

Shares of MMS traded up $0.08 during trading hours on Friday, reaching $68.18. 456,343 shares of the stock traded hands, compared to its average volume of 531,908. Maximus, Inc. has a 52 week low of $63.77 and a 52 week high of $93.97. The company has a market cap of $3.86 billion, a price-to-earnings ratio of 14.66 and a beta of 0.71. The stock has a fifty day simple moving average of $70.00 and a 200 day simple moving average of $77.89. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82.

Maximus (NYSE:MMS - Get Free Report) last posted its earnings results on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. On average, equities analysts forecast that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Saturday, February 15th were issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.76%. The ex-dividend date was Friday, February 14th. Maximus's dividend payout ratio (DPR) is currently 25.81%.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.